|5.95||-0.14 / -2.30%|
Data as of 3:59pm ET
|6.05||+0.10 / +1.68%|
The 4 analysts offering 12-month price forecasts for Amicus Therapeutics Inc have a median target of 8.50, with a high estimate of 14.00 and a low estimate of 7.00. The median estimate represents a +42.86% increase from the last price of 5.95.
The current consensus among 4 polled investment analysts is to Buy stock in Amicus Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.